Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
最新資料
HK$1.965
+HK$0.005 · +0.26%
盤中時間採用HKT。市場資料可能有所延遲。
Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
日內區間
目前HK$1.965
52週區間
目前HK$1.965
盤中時間採用HKT。市場資料可能有所延遲。
Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
日內區間
目前HK$1.965
52週區間
目前HK$1.965
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 3.65億 USD | 3.49億 USD | 3.59億 USD | 3.54億 USD | 2.94億 USD |
| 銷貨成本 | 1.5億 USD | 1.32億 USD | 1.4億 USD | 1.52億 USD | 1.27億 USD |
| 毛利 | 2.15億 USD | 2.17億 USD | 2.2億 USD | 2.02億 USD | 1.67億 USD |
| 研究與開發 | 1686.1萬 USD | 1593.7萬 USD | 1802.9萬 USD | 1802.3萬 USD | 1559.4萬 USD |
| 銷售、一般及管理費用 | 1.66億 USD | 1.65億 USD | 1.59億 USD | 1.29億 USD | 1.01億 USD |
| 營業費用 | 1.83億 USD | 1.81億 USD | 1.77億 USD | 1.47億 USD | 1.16億 USD |
| 利息收入 | 96.24萬 USD | 79萬 USD | 22.2萬 USD | 61.3萬 USD | 54.3萬 USD |
| 利息支出 | 324.98萬 USD | 245.5萬 USD | 206.4萬 USD | 197.2萬 USD | 200.5萬 USD |
| 折舊和攤銷 | 1119.3萬 USD | 1123.1萬 USD | 1423.5萬 USD | 1240.2萬 USD | 1228.5萬 USD |
| 營業利益 | 3255.5萬 USD | 3565.7萬 USD | 4205.9萬 USD | 5544.4萬 USD | 5055.9萬 USD |
| 淨利 | 1901.6萬 USD | 2512.6萬 USD | 3149.9萬 USD | 4017萬 USD | 3124.5萬 USD |
公司資料更新於 2026年10月6日。
報告持有此股票曝險的交易所交易基金。
WisdomTree International SmallCap Dividend FundDLS17.54萬0.02%10.43億 USD0.58%US$86.5471-0.15%
WisdomTree Dynamic International SmallCap Equity ETFDDLS6.93萬0.02%4.17億 USD0.48%US$44.94-0.43%
WisdomTree Dynamic International Equity FundDDWM3.95萬0.00%14.15億 USD0.40%US$45.835+0.17%
Avantis International Small Cap Value ETFAVDV4669.27—202.05億 USD0.36%US$109.090.00%
WisdomTree International SmallCap Dividend FundDLS
WisdomTree Dynamic International SmallCap Equity ETFDDLS
WisdomTree Dynamic International Equity FundDDWM
Avantis International Small Cap Value ETFAVDVAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。